Literature DB >> 16243827

Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.

Akihide Ryo1, Hiroji Uemura, Hitoshi Ishiguro, Tatsuya Saitoh, Akira Yamaguchi, Kilian Perrem, Yoshinobu Kubota, Kun Ping Lu, Ichiro Aoki.   

Abstract

PURPOSE: The peptidyl-prolyl isomrase Pin1 plays a catalytic role in oncogenesis in solid cancers, including prostate cancer. In the present study, we sought to determine the potential of Pin1-targeted gene silencing in inhibiting cellular growth and tumorigenicity in prostate cancer. EXPERIMENTAL
DESIGN: A retrovirus-mediated RNA interference targeting Pin1 was expressed in PC3 and LNCaP cells, and cell growth and several transformed properties were investigated.
RESULTS: The stable expression of Pin1-specific small interfering RNA constructs in PC3 and LNCaP cells significantly reduced cellular proliferation, colony formation, migration, and invasion but strongly enhanced the apoptotic response induced by serum depletion or treatment with anticancer agents. Furthermore, Pin1 depletion significantly suppressed tumorigenic potential in athymic mice, resulting in the inhibition of both tumor growth and angiogeneisis.
CONCLUSIONS: These results strongly suggest that Pin1 plays an important role not only in tumorigenesis but also in the maintenance of the transformed phenotype in prostate cancer cells. Hence, Pin1 may serve as a promising therapeutic target, particularly for recurrent prostate tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243827     DOI: 10.1158/1078-0432.CCR-05-0457

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  47 in total

1.  Relevance Rank Platform (RRP) for Functional Filtering of High Content Protein-Protein Interaction Data.

Authors:  Yuba Raj Pokharel; Jani Saarela; Agnieszka Szwajda; Christian Rupp; Anne Rokka; Shibendra Lal Kumar Karna; Kaisa Teittinen; Garry Corthals; Olli Kallioniemi; Krister Wennerberg; Tero Aittokallio; Jukka Westermarck
Journal:  Mol Cell Proteomics       Date:  2015-10-23       Impact factor: 5.911

Review 2.  RNA interference and cancer therapy.

Authors:  Zhaohui Wang; Donald D Rao; Neil Senzer; John Nemunaitis
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

3.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.

Authors:  Tae Ho Lee; Chun-Hau Chen; Futoshi Suizu; Pengyu Huang; Cordelia Schiene-Fischer; Sebastian Daum; Yan Jessie Zhang; Alison Goate; Ruey-Hwa Chen; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Cell       Date:  2011-04-14       Impact factor: 17.970

4.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

Authors:  Joan P Breyer; Kate M McReynolds; Brian L Yaspan; Kevin M Bradley; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

6.  Pin1 facilitates the phosphorylation-dependent ubiquitination of SF-1 to regulate gonadotropin beta-subunit gene transcription.

Authors:  Zhuojuan Luo; Andrea Wijeweera; Yingzi Oh; Yih-Cherng Liou; Philippa Melamed
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

7.  Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.

Authors:  Man-Li Luo; Chang Gong; Chun-Hau Chen; Daniel Y Lee; Hai Hu; Pengyu Huang; Yandan Yao; Wenjun Guo; Ferenc Reinhardt; Gerburg Wulf; Judy Lieberman; Xiao Zhen Zhou; Erwei Song; Kun Ping Lu
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

8.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

10.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.

Authors:  Prudence B Lam; Laura N Burga; Bryan P Wu; Erin W Hofstatter; Kun Ping Lu; Gerburg M Wulf
Journal:  Mol Cancer       Date:  2008-12-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.